DUSK / USDT

DUSK / BTC

ZEN / BTC

XVG / USDT

ZEN / USDT

XVG / TRY

ZEN / USDC

XVG / ETH

WCT / BNB

XNO / BTC

HEMI / TRY

HEMI / USDT

HEMI / USDC

HEMI / FDUSD

PUMP / TRY

PUMP / USDT

PUMP / USDC

ALCX / USDT

SAPIEN / TRY

MMT / TRY

SYLVAN PLYBOARD (INDIA) L

WINNY IMMIGRA & EDU SER L

VLS FINANCE LTD

BILLIONBRAINS GARAGE VN L

ARABIAN PETROLEUM LIMITED

BANNARI AM SPIN MILL LTD.

CANARYS AUTOMATIONS LTD

ENERGY DEVE. CO.LTD

ON DOOR CONCEPTS LIMITED

MACPOWER CNC MACHINES LTD

INDIAN EMULSIFERS LTD

BLUE PEBBLE LIMITED

VASWANI IND LTD

DELTA AUTOCORP LIMITED

S A TECH SOFTWARE INDIA L

RAJGOR CASTOR DERIVATI L

BOMBAY METRICS S C LTD

GABRIEL INDIA LTD

INTERIORS & MORE LIMITED

PARAMOUNT DYE TEC LIMITED

Click here to get full coverage on GLAXOSMITHKLINE PHARMA LT (GLAXO.NS) Q3 24/25 earnings call transcript - Yahoo Finance

GLAXOSMITHKLINE PHARMA LT (GLAXO.NS) Q3 24/25 earnings call transcript  Yahoo Finance

GLAXOSMITHKLINE PHARMA LT (GLAXO.NS) Q3 24/25 earnings call transcript - Yahoo Finance

Click here to get full coverage on GLAXOSMITHKLINE PHARMA LT (GLAXO.NS) Q1 25/26 earnings call transcript - Yahoo Finance

GLAXOSMITHKLINE PHARMA LT (GLAXO.NS) Q1 25/26 earnings call transcript  Yahoo Finance

GLAXOSMITHKLINE PHARMA LT (GLAXO.NS) Q1 25/26 earnings call transcript - Yahoo Finance

Click here to get full coverage on Lali Espósito, Esteban Lamothe, Marcelo Subiotto to Star In Benjamín Naishtat’s ‘Glaxo,’ Produced by RT Features and Rei Pictures (EXCLUSIVE) - Variety

Lali Espósito, Esteban Lamothe, Marcelo Subiotto to Star In Benjamín Naishtat’s ‘Glaxo,’ Produced by RT Features and Rei Pictures (EXCLUSIVE)  Variety

Lali Espósito, Esteban Lamothe, Marcelo Subiotto to Star In Benjamín Naishtat’s ‘Glaxo,’ Produced by RT Features and Rei Pictures (EXCLUSIVE) - Variety

Click here to get full coverage on GSK commits $30 billion to US research and development, factory expansion, as Trump visits UK - Reuters

GSK commits $30 billion to US research and development, factory expansion, as Trump visits UK  Reuters

GSK commits $30 billion to US research and development, factory expansion, as Trump visits UK - Reuters

Click here to get full coverage on Bristol Post-Punks Glaxo Babies Share First New Music In 35 Years - Stereogum

Bristol Post-Punks Glaxo Babies Share First New Music In 35 Years  Stereogum

Bristol Post-Punks Glaxo Babies Share First New Music In 35 Years - Stereogum

Click here to get full coverage on While individual investors own 14% of GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO), public companies are its largest shareholders with 75% ownership - simplywall.st

While individual investors own 14% of GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO), public companies are its largest shareholders with 75% ownership  simplywall.st

While individual investors own 14% of GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO), public companies are its largest shareholders with 75% ownership - simplywall.st

Click here to get full coverage on GLAXOSMITHKLINE PHARMA LT (GLAXO.NS) Q2 24/25 earnings call transcript - Yahoo Finance

GLAXOSMITHKLINE PHARMA LT (GLAXO.NS) Q2 24/25 earnings call transcript  Yahoo Finance

GLAXOSMITHKLINE PHARMA LT (GLAXO.NS) Q2 24/25 earnings call transcript - Yahoo Finance

Click here to get full coverage on GlaxoSmithKline India reports higher second-quarter profit on specialty medicine growth - Reuters

GlaxoSmithKline India reports higher second-quarter profit on specialty medicine growth  Reuters

GlaxoSmithKline India reports higher second-quarter profit on specialty medicine growth - Reuters

Click here to get full coverage on GLAXOSMITHKLINE PHARMA LT (GLAXO.NS) Q1 24/25 earnings call transcript - Yahoo Finance

GLAXOSMITHKLINE PHARMA LT (GLAXO.NS) Q1 24/25 earnings call transcript  Yahoo Finance

GLAXOSMITHKLINE PHARMA LT (GLAXO.NS) Q1 24/25 earnings call transcript - Yahoo Finance

Click here to get full coverage on India's GlaxoSmithKline Pharma reports higher profit on strong demand for respiratory drugs - Reuters

India's GlaxoSmithKline Pharma reports higher profit on strong demand for respiratory drugs  Reuters

India's GlaxoSmithKline Pharma reports higher profit on strong demand for respiratory drugs - Reuters

Click here to get full coverage on Breakingviews - GSK revenue hole raises chances of risky M&A move - Reuters

Breakingviews - GSK revenue hole raises chances of risky M&A move  Reuters

Breakingviews - GSK revenue hole raises chances of risky M&A move - Reuters

Click here to get full coverage on GLAXOSMITHKLINE PHARMA LT (GLAXO.NS) Q2 25/26 earnings call transcript - Yahoo Finance

GLAXOSMITHKLINE PHARMA LT (GLAXO.NS) Q2 25/26 earnings call transcript  Yahoo Finance

GLAXOSMITHKLINE PHARMA LT (GLAXO.NS) Q2 25/26 earnings call transcript - Yahoo Finance

Click here to get full coverage on India's GlaxoSmithKline Pharma reports profit rise on strong demand - Reuters

India's GlaxoSmithKline Pharma reports profit rise on strong demand  Reuters

India's GlaxoSmithKline Pharma reports profit rise on strong demand - Reuters

Click here to get full coverage on Will Glaxo (GSK) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance

Will Glaxo (GSK) Beat Estimates Again in Its Next Earnings Report?  Yahoo Finance

Will Glaxo (GSK) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance

Click here to get full coverage on Glaxo (GSK) Up 8% Since Last Earnings Report: Can It Continue? - Yahoo Finance

Glaxo (GSK) Up 8% Since Last Earnings Report: Can It Continue?  Yahoo Finance

Glaxo (GSK) Up 8% Since Last Earnings Report: Can It Continue? - Yahoo Finance

Click here to get full coverage on Glaxo (GSK) Up 3.2% Since Last Earnings Report: Can It Continue? - Yahoo Finance

Glaxo (GSK) Up 3.2% Since Last Earnings Report: Can It Continue?  Yahoo Finance

Glaxo (GSK) Up 3.2% Since Last Earnings Report: Can It Continue? - Yahoo Finance

Click here to get full coverage on Annual Report 2024 - GSK

Annual Report 2024 - GSK

Click here to get full coverage on GSK Egypt posts lower consolidated net profits in 9M-25 - ZAWYA

GSK Egypt posts lower consolidated net profits in 9M-25  ZAWYA

GSK Egypt posts lower consolidated net profits in 9M-25 - ZAWYA

Click here to get full coverage on GSK CEO Walmsley to exit as insider Miels tapped to rev up pipeline - Reuters

GSK CEO Walmsley to exit as insider Miels tapped to rev up pipeline  Reuters

GSK CEO Walmsley to exit as insider Miels tapped to rev up pipeline - Reuters

Click here to get full coverage on GSK’s Emma Walmsley to step down as CEO - European Pharmaceutical Review

GSK’s Emma Walmsley to step down as CEO  European Pharmaceutical Review

GSK’s Emma Walmsley to step down as CEO - European Pharmaceutical Review

Click here to get full coverage on India's GlaxoSmithKline Pharma posts first revenue drop in over two years - Yahoo Finance Singapore

India's GlaxoSmithKline Pharma posts first revenue drop in over two years  Yahoo Finance Singapore

India's GlaxoSmithKline Pharma posts first revenue drop in over two years - Yahoo Finance Singapore

Click here to get full coverage on Zantac Lawsuit Update - Lawsuit Information Center

Zantac Lawsuit Update  Lawsuit Information Center

Zantac Lawsuit Update - Lawsuit Information Center

Click here to get full coverage on GlaxoSmithKline Pharmaceuticals Enhances Investor Communication - TipRanks

GlaxoSmithKline Pharmaceuticals Enhances Investor Communication  TipRanks

GlaxoSmithKline Pharmaceuticals Enhances Investor Communication - TipRanks

Click here to get full coverage on GSK seeks FDA nod for expanded use of RSV vaccine in adults - Reuters

GSK seeks FDA nod for expanded use of RSV vaccine in adults  Reuters

GSK seeks FDA nod for expanded use of RSV vaccine in adults - Reuters

Click here to get full coverage on UK's drug-cost watchdog recommends use of GSK unit's HIV prevention drug - Reuters

UK's drug-cost watchdog recommends use of GSK unit's HIV prevention drug  Reuters

UK's drug-cost watchdog recommends use of GSK unit's HIV prevention drug - Reuters

Click here to get full coverage on GlaxoSmithKline expands mRNA wars, suing Moderna at the UPC - IAM Patent

GlaxoSmithKline expands mRNA wars, suing Moderna at the UPC  IAM Patent

GlaxoSmithKline expands mRNA wars, suing Moderna at the UPC - IAM Patent

Click here to get full coverage on GlaxoSmithKline Stock (GSK) Up as CEO Emma Walmsley Steps Down for Luke Miels - TipRanks

GlaxoSmithKline Stock (GSK) Up as CEO Emma Walmsley Steps Down for Luke Miels  TipRanks

GlaxoSmithKline Stock (GSK) Up as CEO Emma Walmsley Steps Down for Luke Miels - TipRanks

Click here to get full coverage on Is Weakness In GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects? - simplywall.st

Is Weakness In GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?  simplywall.st

Is Weakness In GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects? - simplywall.st

Click here to get full coverage on GSK launches $2.5 billion buyback, lifts sales target after stellar fourth quarter - Reuters

GSK launches $2.5 billion buyback, lifts sales target after stellar fourth quarter  Reuters

GSK launches $2.5 billion buyback, lifts sales target after stellar fourth quarter - Reuters

Click here to get full coverage on GSK's asthma drug wins FDA approval to treat 'smoker's lung' - Reuters

GSK's asthma drug wins FDA approval to treat 'smoker's lung'  Reuters

GSK's asthma drug wins FDA approval to treat 'smoker's lung' - Reuters

Click here to get full coverage on GlaxoSmithKline (GSK) Bets on Politics and U.S. Pipeline to Reclaim Pharma Prominence - TipRanks

GlaxoSmithKline (GSK) Bets on Politics and U.S. Pipeline to Reclaim Pharma Prominence  TipRanks

GlaxoSmithKline (GSK) Bets on Politics and U.S. Pipeline to Reclaim Pharma Prominence - TipRanks

Click here to get full coverage on GlaxoSmithKline to cut 150 jobs in Cambridge, Mass. - The Business Journals

GlaxoSmithKline to cut 150 jobs in Cambridge, Mass.  The Business Journals

GlaxoSmithKline to cut 150 jobs in Cambridge, Mass. - The Business Journals

Click here to get full coverage on GlaxoSmithKline stock forecast | Is GSK a Good Stock to Buy? - Capital.com

GlaxoSmithKline stock forecast | Is GSK a Good Stock to Buy?  Capital.com

GlaxoSmithKline stock forecast | Is GSK a Good Stock to Buy? - Capital.com

Click here to get full coverage on GlaxoSmithKline Pharmaceuticals Limited's (NSE:GLAXO) Business Is Yet to Catch Up With Its Share Price - simplywall.st

GlaxoSmithKline Pharmaceuticals Limited's (NSE:GLAXO) Business Is Yet to Catch Up With Its Share Price  simplywall.st

GlaxoSmithKline Pharmaceuticals Limited's (NSE:GLAXO) Business Is Yet to Catch Up With Its Share Price - simplywall.st

Click here to get full coverage on Optimising efficiency, traceability, and integration with liquid handling for GlaxoSmithKline - Labmate Online

Optimising efficiency, traceability, and integration with liquid handling for GlaxoSmithKline  Labmate Online

Optimising efficiency, traceability, and integration with liquid handling for GlaxoSmithKline - Labmate Online

Click here to get full coverage on GSK to Inject ‘Tens of Billions’ in US Amid Trump’s Tariffs, Pipeline Reshuffles - BioSpace

GSK to Inject ‘Tens of Billions’ in US Amid Trump’s Tariffs, Pipeline Reshuffles  BioSpace

GSK to Inject ‘Tens of Billions’ in US Amid Trump’s Tariffs, Pipeline Reshuffles - BioSpace

Click here to get full coverage on GlaxoSmithKline Pharmaceuticals Limited Just Missed Revenue By 8.6%: Here's What Analysts Think Will Happen Next - simplywall.st

GlaxoSmithKline Pharmaceuticals Limited Just Missed Revenue By 8.6%: Here's What Analysts Think Will Happen Next  simplywall.st

GlaxoSmithKline Pharmaceuticals Limited Just Missed Revenue By 8.6%: Here's What Analysts Think Will Happen Next - simplywall.st

Click here to get full coverage on Inclusion - GSK

Inclusion - GSK

Click here to get full coverage on GSK pays $1.2B upfront for Boston Pharmaceuticals' lead liver disease drug - Fierce Biotech

GSK pays $1.2B upfront for Boston Pharmaceuticals' lead liver disease drug  Fierce Biotech

GSK pays $1.2B upfront for Boston Pharmaceuticals' lead liver disease drug - Fierce Biotech

Click here to get full coverage on US FDA approves GSK's combo meningococcal vaccine - Reuters

US FDA approves GSK's combo meningococcal vaccine  Reuters

US FDA approves GSK's combo meningococcal vaccine - Reuters

Click here to get full coverage on Role And Value Of The Marketing Audit In Glaxosmithkline And Its Sustainability Process - vocal.media

Role And Value Of The Marketing Audit In Glaxosmithkline And Its Sustainability Process  vocal.media

Role And Value Of The Marketing Audit In Glaxosmithkline And Its Sustainability Process - vocal.media

Click here to get full coverage on GLAXO Share Price Today - GlaxoSmithKline Pharmaceuticals on NSE/BSE - scanx.trade

GLAXO Share Price Today - GlaxoSmithKline Pharmaceuticals on NSE/BSE  scanx.trade

GLAXO Share Price Today - GlaxoSmithKline Pharmaceuticals on NSE/BSE - scanx.trade

Click here to get full coverage on GlaxoSmithKline Will Get $500M In CureVac-Pfizer Patent Deal - Law360

GlaxoSmithKline Will Get $500M In CureVac-Pfizer Patent Deal  Law360

GlaxoSmithKline Will Get $500M In CureVac-Pfizer Patent Deal - Law360

Click here to get full coverage on Arizona Attorney General Sues to Hold Pharmaceutical Company GlaxoSmithKline Accountable for Endangering Asthma Patients - DiCello Levitt

Arizona Attorney General Sues to Hold Pharmaceutical Company GlaxoSmithKline Accountable for Endangering Asthma Patients  DiCello Levitt

Arizona Attorney General Sues to Hold Pharmaceutical Company GlaxoSmithKline Accountable for Endangering Asthma Patients - DiCello Levitt

Click here to get full coverage on Emma Walmsley, big pharma’s first female CEO, to depart GSK - BioPharma Dive

Emma Walmsley, big pharma’s first female CEO, to depart GSK  BioPharma Dive

Emma Walmsley, big pharma’s first female CEO, to depart GSK - BioPharma Dive

Click here to get full coverage on Cautious Outlook on GlaxoSmithKline Despite Strong Financial Performance: Sell Rating Due to Market Headwinds and Modest Guidance Upgrades - TipRanks

Cautious Outlook on GlaxoSmithKline Despite Strong Financial Performance: Sell Rating Due to Market Headwinds and Modest Guidance Upgrades  TipRanks

Cautious Outlook on GlaxoSmithKline Despite Strong Financial Performance: Sell Rating Due to Market Headwinds and Modest Guidance Upgrades - TipRanks

Click here to get full coverage on GSK shares fall as narrow approval of blood cancer drug limits US relaunch - Reuters

GSK shares fall as narrow approval of blood cancer drug limits US relaunch  Reuters

GSK shares fall as narrow approval of blood cancer drug limits US relaunch - Reuters

Click here to get full coverage on Grants and donations - GSK

Grants and donations - GSK

Click here to get full coverage on Arizona says GlaxoSmithKline's greed endangered kids with asthma - azcentral.com and The Arizona Republic

Arizona says GlaxoSmithKline's greed endangered kids with asthma  azcentral.com and The Arizona Republic

Arizona says GlaxoSmithKline's greed endangered kids with asthma - azcentral.com and The Arizona Republic

Click here to get full coverage on End of production at GSK's Ulverston site 'a sad day' - BBC

End of production at GSK's Ulverston site 'a sad day'  BBC

End of production at GSK's Ulverston site 'a sad day' - BBC

Click here to get full coverage on GSK share price still low after +6% rise after bullish earnings call - Good Money Guide

GSK share price still low after +6% rise after bullish earnings call  Good Money Guide

GSK share price still low after +6% rise after bullish earnings call - Good Money Guide

Click here to get full coverage on GSK to buy cancer-focused IDRx in $1 billion deal - statnews.com

GSK to buy cancer-focused IDRx in $1 billion deal  statnews.com

GSK to buy cancer-focused IDRx in $1 billion deal - statnews.com

Click here to get full coverage on GlaxoSmithKline seen as favourite to buy Pfizer's consumer healthcare unit after Reckitt Benckiser ends interest - FirstWord Pharma

GlaxoSmithKline seen as favourite to buy Pfizer's consumer healthcare unit after Reckitt Benckiser ends interest  FirstWord Pharma

GlaxoSmithKline seen as favourite to buy Pfizer's consumer healthcare unit after Reckitt Benckiser ends interest - FirstWord Pharma

Click here to get full coverage on A Major Drug Company Now Has Access to 23andMe’s Genetic Data. Should You Be Concerned? - Time Magazine

A Major Drug Company Now Has Access to 23andMe’s Genetic Data. Should You Be Concerned?  Time Magazine

A Major Drug Company Now Has Access to 23andMe’s Genetic Data. Should You Be Concerned? - Time Magazine

Click here to get full coverage on GlaxoSmithKline Pharmaceuticals shares hit 20% upper circuit as profit jumps fivefold in Q3FY25 - livemint.com

GlaxoSmithKline Pharmaceuticals shares hit 20% upper circuit as profit jumps fivefold in Q3FY25  livemint.com

GLAXO

Price Chart

Key Statistics

Technicals

About GLAXO

Latest News

GLAXOSMITHKLINE PHARMA LT (GLAXO.NS) Q3 24/25 earnings call transcript - Yahoo Finance

GLAXOSMITHKLINE PHARMA LT (GLAXO.NS) Q1 25/26 earnings call transcript - Yahoo Finance

Lali Espósito, Esteban Lamothe, Marcelo Subiotto to Star In Benjamín Naishtat’s ‘Glaxo,’ Produced by RT Features and Rei Pictures (EXCLUSIVE) - Variety

Advanced Charts

Top Gainers

Top Losers